The cardiovascular protection offered by GLP-1 receptor agonists stems from several complementary mechanisms: Anti-inflammatory effects through suppression of CRP, TNF-, and other inflammatory markers Substantial weight reduction, particularly with higher doses of newer agents Blood pressure modulation via direct vascular effects and enhanced natriuresis Improved endothelial function and lipid profiles Renal protective effects, including reduced albuminuria and slowed eGFR decline Though initially established in type 2 diabetes populations, recent evidence from the SELECT trial confirms these benefits extend to non-diabetic patients with obesity and established cardiovascular disease
Cool inferior frontostriatal dysfunction in attention-deficit/hyperactivity disorder versus hot ventromedial orbitofrontal-limbic dysfunction in conduct disorder: a review
(BPT) - If you've been denied access to a GLP-1 medication for weight loss, you are not alone
But theory and practice are not the same thing
Detailed nutritional guidance is available through several resources: best foods to eat on semaglutide , foods to avoid on tirzepatide , tirzepatide diet plan , semaglutide diet plan , and complete food lists for semaglutide users
